GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...

For Dr Alexandra Sowa, author of ‘The Ozempic Revolution’, getting onto GLP-1 drugs like Mounjaro or Ozempic is not a ...

OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

The European Commission has given the fast-fashion retailer one month to rectify practices the bloc believes could be ...

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. The prescription drugs market will grow from $1,240.33B in 2024 to $2,151.63B by ...

Drugmakers are introducing discounts and lower-cost options for consumers who have to pay for GLP-1 drugs out of pocket. News outlets look at the trend in pricing for drugs like Wegovy and Zepbound.

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall ...